In the complex world of pharmaceutical manufacturing, the quality and availability of raw materials and intermediates are paramount. One such critical compound is (3,4-Dimethoxyphenyl)acetonitrile (CAS 93-17-4), an essential precursor in the synthesis of cefuroxime, a widely prescribed second-generation cephalosporin antibiotic. For researchers, formulators, and procurement specialists, understanding the chemical significance of this intermediate and securing a reliable supply chain is crucial. This article delves into the pivotal role of (3,4-Dimethoxyphenyl)acetonitrile in cefuroxime production and guides buyers on how to source this vital compound effectively.

(3,4-Dimethoxyphenyl)acetonitrile: A Cornerstone Intermediate

(3,4-Dimethoxyphenyl)acetonitrile, identified by CAS number 93-17-4, is a fine chemical intermediate that plays a foundational role in building the molecular structure of more complex pharmaceutical compounds. With its specific arrangement of methoxy groups and the nitrile functional group, it provides a versatile starting point for various chemical reactions. Its molecular formula, C10H11NO2, and molecular weight of 177.2 are key identifiers for chemists and quality control personnel.

The Synthesis of Cefuroxime: Where (3,4-Dimethoxyphenyl)acetonitrile Shines

Cefuroxime is a potent antibiotic effective against a broad spectrum of Gram-positive and Gram-negative bacteria. Its synthesis involves a multi-step chemical process, and (3,4-Dimethoxyphenyl)acetonitrile serves as a critical building block in one of the key pathways. The compound's phenylacetonitrile moiety is instrumental in constructing the characteristic side chain of the cephalosporin nucleus, which is essential for the drug's antibacterial activity. The precise functional groups within (3,4-Dimethoxyphenyl)acetonitrile facilitate specific bond formations and transformations required to achieve the final cefuroxime molecule.

The importance of a high-purity intermediate cannot be overstated in API synthesis. Impurities in starting materials can lead to unwanted byproducts, reduced yields, and, critically, compromised drug safety and efficacy. Therefore, sourcing (3,4-Dimethoxyphenyl)acetonitrile with guaranteed high purity (e.g., ≥99%) from reputable manufacturers is non-negotiable for pharmaceutical companies.

Sourcing and Procurement Strategies

For pharmaceutical manufacturers and research institutions, securing a consistent and high-quality supply of (3,4-Dimethoxyphenyl)acetonitrile is a strategic imperative. When looking to purchase this intermediate, consider the following:

• Manufacturer Reputation: Engage with established manufacturers who specialize in pharmaceutical intermediates. Companies like NINGBO INNO PHARMCHEM CO.,LTD., a China-based supplier, are known for their quality control and production capabilities for compounds like (3,4-Dimethoxyphenyl)acetonitrile.
• Purity and Documentation: Always demand a Certificate of Analysis (CoA) detailing the purity, physical properties, and analytical methods used. For large-scale procurement, regulatory support documentation may also be necessary.
• Price Negotiation: Obtain quotes from multiple suppliers to ensure competitive pricing, especially for bulk orders. Understand that factors like scale, purity, and delivery terms influence the final price.
• Supply Chain Reliability: Assess the supplier's production capacity, lead times, and logistics to ensure uninterrupted supply for your manufacturing operations.

By prioritizing these aspects, procurement managers can ensure they are obtaining the best possible value and quality for their (3,4-Dimethoxyphenyl)acetonitrile requirements, thereby safeguarding the integrity of the cefuroxime manufacturing process. The availability of this compound from experienced suppliers in China significantly supports global pharmaceutical production.

In conclusion, (3,4-Dimethoxyphenyl)acetonitrile (CAS 93-17-4) is more than just a chemical compound; it is a fundamental component in the production of a life-saving antibiotic. By understanding its role and implementing smart procurement strategies, businesses can ensure a stable supply of this vital intermediate, contributing to accessible healthcare worldwide.